Related Experiment Video
Updated: Jun 8, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
222
Survival Disparities among Cancer Patients Based on Mobility Patterns: A Population-Based Study
Fengyu Wen1,2, Yike Zhang3,4, Chao Yang5,6,7
1Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
Health Data Science
|November 6, 2024
Summary
Cancer patient mobility impacts survival. Traveling to specialized centers, like local or national hubs, is linked to better survival rates compared to staying within one city. Improving cancer care in underserved areas is essential.
Area of Science:
- Oncology
- Health Services Research
- Epidemiology
Background:
- Cancer poses a significant global health challenge.
- Unequal distribution of medical resources drives cancer patient travel.
- Understanding patient mobility patterns is crucial for improving cancer care.
Purpose of the Study:
- To evaluate the association between cancer patient mobility patterns and survival outcomes.
- To analyze survival disparities based on intra-city, local center, and national center mobility patterns.
- To identify factors influencing survival in cancer patients who travel for treatment.
Main Methods:
- Utilized data from 20,602 cancer patients hospitalized between 2015-2017 in China.
- Defined three mobility patterns: intra-city, local center, and national center.
- Employed propensity score matching to compare survival rates across mobility patterns, adjusting for key patient characteristics.
Main Results:
- Patients traveling to local or national centers showed higher 5-year survival rates than intra-city patients.
- Local center pattern: 69.3% survival (HR 0.85, CI 0.77-0.95).
- National center pattern: 69.3% survival (HR 0.80, CI 0.67-0.97).
Conclusions:
- Significant survival disparities exist among cancer patients based on their mobility patterns.
- Enhanced cancer care quality is vital, particularly in regions with limited healthcare resources.
- Patient mobility is a key factor to consider in cancer care delivery and outcome assessment.
Related Concept Videos
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:20Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K